Critical care medicine is the discipline of caring for patients with acute life-threatening conditions or conditions likely to cause serious harm if not rapidly addressed. This work requires a detailed understanding of human physiology, the pathophysiology of severe illness and injury, the intricate interactions between organ systems and therapies, as well as an understanding of and experience with the rapidly changing technologies available in a modern pediatric intensive care unit (PICU). The science of caring for the critically ill patient continues to advance rapidly as the molecular mediators of illness have become better defined and new therapies are brought into clinical use. Critical care, then, is a highly complex, multidisciplinary field in which optimal patient outcomes require a team-oriented approach, including critical care physicians and nurses; respiratory therapists; pharmacists; consulting specialists; physical, occupational and recreational therapists; and social services specialists.
RESPIRATORY CRITICAL CARE
ACUTE RESPIRATORY FAILURE
ESSENTIALS OF DIAGNOSIS & TYPICAL FEATURES
Inability to deliver oxygen or remove carbon dioxide.
PaO2 is low while PaCO2 is normal in hypoxemic respiratory failure (ventilation/perfusion [V/Q] mismatch, diffusion defects, and intrapulmonary shunt).
PaO2 is low and PaCO2 is high in hypercapnic respiratory failure (alveolar hypoventilation seen in central nervous system [CNS] dysfunction, oversedation, neuromuscular disorders).
Noninvasive mechanical ventilation can be an effective treatment for hypercapnic respiratory failure and selected patients with hypoxemic failure.
Conventional mechanical ventilation should be accomplished within a strategy of “lung-protective” ventilation.
High-frequency oscillatory ventilation (HFOV) and extracorporeal membrane oxygenation (ECMO) are viable options for patients failing conventional mechanical ventilation.
Acute respiratory failure, defined as the inability of the respiratory system to adequately deliver oxygen or remove carbon dioxide, is a major cause of morbidity and mortality in infants and children. Anatomic and developmental differences place infants and young children at higher risk than adults for respiratory failure. An infant’s thoracic cage is more compliant than that of the adult or older child, allowing a greater tendency toward alveolar collapse. The intercostal muscles are poorly developed and unable to achieve the “bucket-handle” motion characteristic of adult breathing, and the diaphragm is shorter and relatively flat with fewer type I muscle fibers, making it less effective and more easily fatigued. The infant’s airways are smaller in caliber than those in older children and adults, resulting in greater resistance to airflow and greater susceptibility to occlusion by mucus plugging and mucosal edema, particularly in the setting of respiratory infections. Compared with adults, the alveoli of children are smaller and have less collateral ventilation, again resulting in a greater tendency to collapse and develop atelectasis. Finally, young infants may have an especially reactive pulmonary vascular bed, impaired immune system, or residual effects from prematurity, all of which increase the risk of respiratory failure.
Respiratory failure can be due to inadequate oxygenation (hypoxemic respiratory failure) or inadequate ventilation (hypercapnic respiratory ...